News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,018 Results
Type
Article (8037)
Company Profile (152)
Press Release (481829)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166763)
Career Advice (304)
Deals (25752)
Drug Delivery (7)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238216)
Policy (17899)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (13)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33163)
ALS (123)
Alzheimer's disease (1027)
Antibody-drug conjugate (ADC) (339)
Approvals (10503)
Artificial intelligence (387)
ASCO (160)
Autoimmune disease (262)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (65)
BIOSECURE Act (1)
Biosimilars (128)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (34)
Bladder cancer (150)
Brain cancer (38)
Breast cancer (559)
Cancer (4174)
Cardiovascular disease (253)
Career advice (245)
Career pathing (1)
CAR-T (196)
CDC (2)
CDMO (39)
Celiac Disease (3)
Cell therapy (540)
Cervical cancer (39)
Clinical research (48681)
Collaboration (1396)
Commercialization (35)
Compensation (1677)
Complete response letters (37)
COVID-19 (779)
CRISPR (75)
CRO (1)
C-suite (875)
Cystic fibrosis (89)
Data (6795)
Denatured (4)
Depression (109)
Dermatology (107)
Diabetes (393)
Diagnostics (4300)
Digital health (45)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (180)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (177)
Earnings (74583)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89331)
Executive appointments (745)
Eye disease (8)
FDA (12762)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (26)
Funding (1017)
Gene editing (140)
Generative AI (15)
Gene therapy (363)
GLP-1 (325)
Government (953)
Grass and pollen (2)
Guidances (288)
Healthcare (9454)
Hematology (115)
HIV (60)
Huntington's disease (30)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (82)
Immunology and inflammation (115)
Immuno-oncology (76)
Indications (191)
Infectious disease (989)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (279)
Interviews (41)
IPO (12408)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (93)
Layoffs (59)
Legal (5195)
Licensing (73)
Liver cancer (47)
Longevity (28)
Lung cancer (594)
Lung diease (11)
Lymphoma (285)
Machine learning (30)
Management (3)
Manufacturing (636)
Marketing (27)
MASH (131)
Medical affairs (2)
Medical device (8735)
Medtech (8938)
Melanoma (15)
Mergers & acquisitions (14506)
Metabolic disorders (804)
mRNA (85)
Multiple sclerosis (119)
Multispecific (4)
NASH (4)
Netherlands (4)
Neurodegenerative disease (250)
Neuropsychiatric disorders (41)
Neuroscience (2007)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (845)
Obesity (251)
Opinion (10)
Ovarian cancer (186)
Pain (196)
Pancreatic cancer (240)
Parkinson's disease (222)
Partnered (12)
Patents (539)
Patient advocacy (4)
Patient recruitment (550)
Patient selection (61)
Peanut (34)
People (41591)
Peptides (26)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15723)
Phase 2 (21778)
Phase 3 (14683)
Pipeline (9199)
Policy (20)
Postmarket research (1570)
Preclinical (6631)
Press Release (34)
Prostate cancer (214)
Psychedelics (14)
Radiopharmaceuticals (206)
Rare diseases (644)
Real estate (3025)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15287)
Reports (27)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (48)
RNA editing (9)
RSV (52)
Schizophrenia (112)
Series A (179)
Series B (130)
Service/supplier (5)
Sickle cell disease (70)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2021)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (57)
Switzerland (2)
Tariffs (2)
Vaccines (369)
Venture capital (18)
Weight loss (84)
Wet AMD (4)
Women's health (103)
Date
Today (65)
Last 7 days (502)
Last 30 days (2417)
Last 365 days (19212)
2026 (17609)
2025 (19252)
2024 (22987)
2023 (26538)
2022 (34586)
2021 (37168)
2020 (33474)
2019 (23269)
2018 (17478)
2017 (18773)
2016 (17925)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (234)
Alabama (81)
Alaska (2)
Arizona (333)
Arkansas (12)
Asia (18118)
Australia (2131)
California (13472)
Canada (3477)
China (597)
Colorado (556)
Connecticut (473)
Delaware (238)
Europe (24919)
Florida (2007)
Georgia (423)
Hawaii (3)
Idaho (46)
Illinois (807)
India (67)
Indiana (340)
Iowa (19)
Japan (476)
Kansas (106)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1326)
Massachusetts (8816)
Michigan (327)
Minnesota (625)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (143)
New Hampshire (61)
New Jersey (2969)
New Mexico (12)
New York (3143)
North Carolina (1418)
North Dakota (4)
Northern California (6845)
Ohio (312)
Oklahoma (15)
Oregon (17)
Pennsylvania (2510)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (82)
South Dakota (1)
Southern California (5641)
Tennessee (134)
Texas (2229)
United States (43566)
Utah (407)
Vermont (1)
Virginia (170)
Washington D.C. (39)
Washington State (1026)
West Virginia (1)
Wisconsin (84)
Wyoming (1)
490,018 Results for "expedeon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
Expedeon AG mandates ODDO SEYDLER BANK AG as Designated Sponsor
ODDO SEYDLER BANK AG will henceforth be the second Designated Sponsor of Expedeon AG’s share, as Expedeon announced.
June 12, 2019
·
2 min read
Business
Expedeon Reports First Quarter 2019 Financial Results
Expedeon AG reported results for the first quarter ended March 31, 2019.
May 9, 2019
·
3 min read
Business
Expedeon Announces Supervisory Board Changes
Expedeon AG announced that Dr. Cristina Garmendia Mendizábal is to step down as chairwoman of the supervisory board effective April 4, 2019.
March 14, 2019
·
2 min read
Deals
Expedeon AG announces Outcome of Annual General Meeting 2019
Expedeon AG announced that the Annual General Meeting held in Heidelberg yesterday, July 09, 2019, approved all management proposals.
July 10, 2019
·
3 min read
Press Releases
Mint Pharmaceuticals Inc. and Bayer Inc. Expand Distribution Partnership in Canada
October 6, 2026
·
3 min read
Expedeon to Present at the Frankfurt Spring Conference
Expedeon AG today announced that CEO Dr Heikki Lanckriet will deliver a presentation on 15 May 2019 at the German Spring Conference in Frankfurt.
May 15, 2019
·
2 min read
Expedeon AG adds ELISA-ONE™ next generation cell signalling assay technology to product offering
Technology developed by Expedeon company TGR BioSciences
May 9, 2019
·
4 min read
Press Releases
Exicure, Inc. Announces Agreement to Sell GPC-100 Program Assets to GPCRT Inc. for KRW 6.5 Billion
November 10, 2026
·
4 min read
Deals
Expedeon AG and Abcam plc close EUR 120 million transaction
Expedeon AG announced the closing of the sale and purchase agreement with Abcam plc, Cambridge, UK, for the sale of the Company’s proteomics and immunology business, as announced on November 11, 2019 and as approved by the Extraordinary Shareholder Meeting on December 19, 2019.
January 5, 2020
·
3 min read
1 of 49,002
Next